Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. (Q39649952)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 February 2012
edit
Language Label Description Also known as
English
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.
scientific article published on 14 February 2012

    Statements

    Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit